Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

152 Médecine à l'acte / médecine au forfait - ANNEXES KCE Reports 85 S Parameter Estimate Standard Error t Value Pr > |t| age*aidsoc 75-84 ans 1 -5661.817112 B 1507.124389 -3.76 0.0002 age*aidsoc 75-84 ans 2 0.000000 B . . . age*aidsoc 85-+ ans 1 0.000000 B . . . age*aidsoc 85-+ ans 2 0.000000 B . . . im*inv 1 1 610.113485 B 251.447551 2.43 0.0153 im*inv 1 2 0.000000 B . . . im*inv 2 1 0.000000 B . . . im*inv 2 2 0.000000 B . . . im*PP0020 1 1 317.710918 B 141.420704 2.25 0.0247 im*PP0020 1 2 0.000000 B . . . im*PP0020 2 1 0.000000 B . . . im*PP0020 2 2 0.000000 B . . . im*prep 1 1 -1727.106211 B 865.520921 -2.00 0.0460 im*prep 1 2 0.000000 B . . . im*prep 2 1 0.000000 B . . . im*prep 2 2 0.000000 B . . . im*VPO 1 1 -426.003129 B 255.554832 -1.67 0.0955 im*VPO 1 2 0.000000 B . . . im*VPO 2 1 0.000000 B . . . im*VPO 2 2 0.000000 B . . . im*chom3 1 1 -730.199951 B 255.765170 -2.85 0.0043 im*chom3 1 2 0.000000 B . . . im*chom3 2 1 0.000000 B . . . im*chom3 2 2 0.000000 B . . . im*aidsoc 1 1 37.173973 B 366.804770 0.10 0.9193 im*aidsoc 1 2 0.000000 B . . . im*aidsoc 2 1 0.000000 B . . . im*aidsoc 2 2 0.000000 B . . . inv*PP0020 1 1 589.280976 B 221.259186 2.66 0.0077 inv*PP0020 1 2 0.000000 B . . . inv*PP0020 2 1 0.000000 B . . . inv*PP0020 2 2 0.000000 B . . . inv*chom3 1 1 -1381.241339 B 954.379410 -1.45 0.1478 inv*chom3 1 2 0.000000 B . . . inv*chom3 2 1 0.000000 B . . . inv*chom3 2 2 0.000000 B . . . inv*aidsoc 1 1 848.929108 B 742.684552 1.14 0.2530 inv*aidsoc 1 2 0.000000 B . . . inv*aidsoc 2 1 0.000000 B . . . inv*aidsoc 2 2 0.000000 B . . . PP0020*prep 1 1 578.673488 B 774.474164 0.75 0.4550 PP0020*prep 1 2 0.000000 B . . . PP0020*prep 2 1 0.000000 B . . . PP0020*prep 2 2 0.000000 B . . . PP0020*VPO 1 1 404.896265 B 237.856082 1.70 0.0887 PP0020*VPO 1 2 0.000000 B . . . PP0020*VPO 2 1 0.000000 B . . . PP0020*VPO 2 2 0.000000 B . . . PP0020*chom3 1 1 177.262004 B 150.838450 1.18 0.2399 PP0020*chom3 1 2 0.000000 B . . . PP0020*chom3 2 1 0.000000 B . . . PP0020*chom3 2 2 0.000000 B . . . PP0020*aidsoc 1 1 25.923461 B 251.832475 0.10 0.9180 PP0020*aidsoc 1 2 0.000000 B . . . PP0020*aidsoc 2 1 0.000000 B . . . PP0020*aidsoc 2 2 0.000000 B . . . prep*VPO 1 1 1580.706379 B 1185.148221 1.33 0.1823 prep*VPO 1 2 0.000000 B . . . prep*VPO 2 1 0.000000 B . . . prep*VPO 2 2 0.000000 B . . . prep*aidsoc 1 1 -203.766441 B 1388.330223 -0.15 0.8833
KCE Reports 85 S Médecine à l'acte : médecine au forfait - ANNEXES 153 Parameter Estimate Standard Error t Value Pr > |t| prep*aidsoc 1 2 0.000000 B . . . prep*aidsoc 2 1 0.000000 B . . . prep*aidsoc 2 2 0.000000 B . . . VPO*chom3 1 1 -508.330347 B 854.447598 -0.59 0.5519 VPO*chom3 1 2 0.000000 B . . . VPO*chom3 2 1 0.000000 B . . . VPO*chom3 2 2 0.000000 B . . . VPO*aidsoc 1 1 1402.367653 B 610.654213 2.30 0.0217 VPO*aidsoc 1 2 0.000000 B . . . VPO*aidsoc 2 1 0.000000 B . . . VPO*aidsoc 2 2 0.000000 B . . . chom3*aidsoc 1 1 15.075190 B 360.637771 0.04 0.9667 chom3*aidsoc 1 2 0.000000 B . . . chom3*aidsoc 2 1 0.000000 B . . . chom3*aidsoc 2 2 0.000000 B . . . The X'X matrix has been found to be singular, and a generalized inverse was used to solve the normal equations. Terms whose estimates are followed by the letter 'B' are not uniquely estimable. Essai 2 - en enlevant les intéractions non significatives Class Level Information Class Levels Values age 7 1-4 ans 25-39 ans 40-64 ans 5-24 ans 65-74 ans 75-84 ans 85-+ ans im 2 1 2 inv 2 1 2 PP0020 2 1 2 prep 2 1 2 VPO 2 1 2 chom3 2 1 2 aidsoc 2 1 2 Number of Observations Read 21778 Number of Observations Used 21778 Source DF Sum of Squares Mean Square F Value Pr > F Model 35 10110794239 288879835.4 25.36 F age 6 3394514543 565752424 49.67
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106: KCE Reports 85 S Médecine à l’a
Page 113 and 114: KCE Reports 85 S Médecine à l'act
Page 155: KCE Reports 85 S Médecine à l'act
Page 207 and 208:
KCE Reports 85 S Médecine à l'act
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
This page is left intentionally bla
Page 247 and 248:
KCE reports 1. Efficacité et renta
Page 249:
74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

Create successful ePaper yourself

Delete template?

Save as template?